COST OF BEST SUPPORTIVE CARE FOR NON-SMALL CELL LUNG CANCER PATIENTS - A GERMAN PERSPECTIVE

被引：1
|
作者：
Schmidt, U. [1 ]
Lipp, R. [2 ]
Drechsler, M. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[2] GermanOncol, Hamburg, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2244
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN86
引用
收藏
页码：A629 / A629
页数：1
相关论文
共 50 条
  • [41] A cost calculation model for specialist palliative care for patients with non-small cell lung cancer in a tertiary centre
    Ostgathe, Christoph
    Walshe, Ronald
    Wolf, Juergen
    Hallek, Michael
    Voltz, Raymond
    SUPPORTIVE CARE IN CANCER, 2008, 16 (05) : 501 - 506
  • [42] Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer
    Atocha Romero
    Roberto Serna-Blasco
    Virginia Calvo
    Mariano Provencio
    Current Treatment Options in Oncology, 2021, 22
  • [43] Evidence for New Standard of Care in Non-Small Cell Lung Cancer Patients
    Smith, Cardinale B.
    Kelley, Amy S.
    Meier, Diane E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2010, 22 (03) : 193 - 194
  • [44] A cost calculation model for specialist palliative care for patients with non-small cell lung cancer in a tertiary centre
    Christoph Ostgathe
    Ronald Walshe
    Jürgen Wolf
    Michael Hallek
    Raymond Voltz
    Supportive Care in Cancer, 2008, 16 : 501 - 506
  • [45] Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer
    Romero, Atocha
    Serna-Blasco, Roberto
    Calvo, Virginia
    Provencio, Mariano
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [46] Early palliative care in patients with metastatic non-small cell lung cancer
    Nieder, Carsten
    Norum, Jan
    ANNALS OF PALLIATIVE MEDICINE, 2012, 1 (01) : 84 - 86
  • [47] SUPPORTIVE CARE VERSUS SUPPORTIVE CARE AND COMBINATION CHEMOTHERAPY IN METASTATIC NON-SMALL CELL LUNG-CANCER - DOES CHEMOTHERAPY MAKE A DIFFERENCE
    GANZ, PA
    FIGLIN, RA
    HASKELL, CM
    LASOTO, N
    SIAU, J
    CANCER, 1989, 63 (07) : 1271 - 1278
  • [48] Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?
    Saha, Antonio
    Rudd, Robin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (02) : 165 - 173
  • [49] Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status
    Satoshi Ikeda
    Hiroshige Yoshioka
    Satoshi Ikeo
    Mitsunori Morita
    Naoyuki Sone
    Takashi Niwa
    Akihiro Nishiyama
    Toshihide Yokoyama
    Akimasa Sekine
    Takashi Ogura
    Tadashi Ishida
    BMC Cancer, 17
  • [50] EGFR gene mutation is not a significant prognostic factor in patients with EGFR mutated non-small cell lung cancer who receive best supportive care alone.
    Masuda, Takeshi
    Wakabayashi, Yu
    Shimoji, Kiyofumi
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Nishimura, Yoshihumi
    Horimasu, Yasushi
    Nakashima, Taku
    Miyamoto, Shintaro
    Senoo, Tadashi
    Iwamoto, Hiroshi
    Ohshimo, Shinichiro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345